Literature DB >> 15181077

Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects.

Mao Fu1, Rasa Kazlauskaite, Maria de Fátima Paiva Baracho, Maria Goretti Do Nascimento Santos, José Brandão-Neto, Sandra Villares, Francesco S Celi, Bernardo L Wajchenberg, Alan R Shuldiner.   

Abstract

Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder caused by mutations in AGPAT2 and Gng3lg. We screened for mutations in AGPAT2 and Gng3lg in 26 families with CGL and one family with Brunzell syndrome. We found mutations in either AGPAT2 or Gng3lg in all but four probands, including three novel mutations in AGPAT2, A712T (Lys215X), IVS3-1G-->C, and C636A (Phe189X). In three siblings with Brunzell syndrome, we identified a splice site mutation (IVS4-2A-->G) in AGPAT2, showing that AGPAT2 mutations can also cause Brunzell syndrome. Eighteen CGL patients from 15 families from the same region of northeastern Brazil were homozygous for a frameshift mutation (669insA of AF05149) in Gng3lg. Despite having the same mutation, the subjects had widely divergent clinical manifestations. In our subjects, there did not appear to be any distinguishing clinical characteristics between CGL subjects with AGPAT2 or Gng3lg mutations with the exception of mental retardation in carriers of Gng3lg. In summary, mutations in AGPAT2 and Gng3lg are approximately equally represented in CGL; despite harboring the same Gng3lg mutation, subjects may have widely divergent clinical manifestations, suggesting modifying influences of other genes and/or environment; and Brunzell syndrome may be caused by a mutation in AGPAT2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181077      PMCID: PMC3390418          DOI: 10.1210/jc.2003-030485

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.

Authors:  H Cao; R A Hegele
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

2.  A case of congenital generalized lipodystrophy: metabolic effects of four dietary regimens. Lack of association of CGL with polymorphism in the lamin A/C Gene.

Authors:  R Kazlauskaite; A T Santomauro; J Goldman; K Silver; S Snitker; B A Beamer; C J Yen; A R Shuldiner; B L Wajchenberg
Journal:  Clin Endocrinol (Oxf)       Date:  2001-03       Impact factor: 3.478

3.  LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

Authors:  S Shackleton; D J Lloyd; S N Jackson; R Evans; M F Niermeijer; B M Singh; H Schmidt; G Brabant; S Kumar; P N Durrington; S Gregory; S O'Rahilly; R C Trembath
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

4.  Congenital lipodystrophy: An endocrine study in three siblings. I. Disorders of carbohydrate metabolism.

Authors:  C Huseman; A Johanson; M Varma; R M Blizzard
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

5.  Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.

Authors:  J Magré; M Delépine; E Khallouf; T Gedde-Dahl; L Van Maldergem; E Sobel; J Papp; M Meier; A Mégarbané; A Bachy; A Verloes; F H d'Abronzo; E Seemanova; R Assan; N Baudic; C Bourut; P Czernichow; F Huet; F Grigorescu; M de Kerdanet; D Lacombe; P Labrune; M Lanza; H Loret; F Matsuda; J Navarro; A Nivelon-Chevalier; M Polak; J J Robert; P Tric; N Tubiana-Rufi; C Vigouroux; J Weissenbach; S Savasta; J A Maassen; O Trygstad; P Bogalho; P Freitas; J L Medina; F Bonnicci; B I Joffe; G Loyson; V R Panz; F J Raal; S O'Rahilly; T Stephenson; C R Kahn; M Lathrop; J Capeau
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

Review 6.  Generalized lipodystrophy, congenital and acquired (lipoatrophy).

Authors:  M Seip; O Trygstad
Journal:  Acta Paediatr Suppl       Date:  1996-06

Review 7.  The structure and functions of human lysophosphatidic acid acyltransferases.

Authors:  D W Leung
Journal:  Front Biosci       Date:  2001-08-01

8.  A gene for congenital generalized lipodystrophy maps to human chromosome 9q34.

Authors:  A Garg; R Wilson; R Barnes; E Arioglu; Z Zaidi; F Gurakan; N Kocak; S O'Rahilly; S I Taylor; S B Patel; A M Bowcock
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

9.  Studies of insulin resistance in congenital generalized lipodystrophy.

Authors:  O Søvik; H Vestergaard; O Trygstad; O Pedersen
Journal:  Acta Paediatr Suppl       Date:  1996-06

10.  Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy.

Authors:  L Van Maldergem; J Magré; T E Khallouf; T Gedde-Dahl; M Delépine; O Trygstad; E Seemanova; T Stephenson; C S Albott; F Bonnici; V R Panz; J L Medina; P Bogalho; F Huet; S Savasta; A Verloes; J J Robert; H Loret; M De Kerdanet; N Tubiana-Rufi; A Mégarbané; J Maassen; M Polak; D Lacombe; C R Kahn; E L Silveira; F H D'Abronzo; F Grigorescu; M Lathrop; J Capeau; S O'Rahilly
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

View more
  21 in total

Review 1.  Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure.

Authors:  J R Porter; T G Barrett
Journal:  J Med Genet       Date:  2005-03-16       Impact factor: 6.318

Review 2.  How lipid droplets "TAG" along: Glycerolipid synthetic enzymes and lipid storage.

Authors:  Huan Wang; Michael V Airola; Karen Reue
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-06-20       Impact factor: 4.698

3.  Face-sparing Congenital Generalized Lipodystrophy Type 1 Associated With Nonclassical Congenital Adrenal Hyperplasia.

Authors:  Sara Costa; Lurdes Sampaio; Ana Berta Sousa; Chao Xing; Anil K Agarwal; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

4.  Congenital generalized lipodystrophy in an Indian patient with a novel mutation in BSCL2 gene.

Authors:  H U Shirwalkar; Z M Patel; J Magre; P Hilbert; L Van Maldergem; R R Mukhopadhyay; A Maitra
Journal:  J Inherit Metab Dis       Date:  2008-08-12       Impact factor: 4.982

Review 5.  Congenital generalized lipodystrophies--new insights into metabolic dysfunction.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Nat Rev Endocrinol       Date:  2015-08-04       Impact factor: 43.330

6.  Energy balance in congenital generalized lipodystrophy type I.

Authors:  Sasha Taleban; Heather T Carew; Helén L Dichek; Samir S Deeb; David Hollenback; David S Weigle; David E Cummings; John D Brunzell
Journal:  Metabolism       Date:  2008-08       Impact factor: 8.694

7.  Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family.

Authors:  Obaid Ur Rahman; Nadeem Khawar; Muhammad Aman Khan; Jawad Ahmed; Kamran Khattak; Jumana Yousuf Al-Aama; Muhammad Naeem; Musharraf Jelani
Journal:  Diagn Pathol       Date:  2013-05-09       Impact factor: 2.644

8.  Altered lipid metabolism in residual white adipose tissues of Bscl2 deficient mice.

Authors:  Weiqin Chen; Hongyi Zhou; Siyang Liu; Cassie J Fhaner; Bethany C Gross; Todd A Lydic; Gavin E Reid
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

Review 9.  What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health.

Authors:  Erica L Scheller; Clifford J Rosen
Journal:  Ann N Y Acad Sci       Date:  2014-03-20       Impact factor: 5.691

10.  Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy.

Authors:  Josivan G Lima; Lucia Helena C Nobrega; Natalia Nobrega de Lima; Maria Goretti do Nascimento Santos; Maria F P Baracho; Selma Maria Bezerra Jeronimo
Journal:  Diabetol Metab Syndr       Date:  2016-03-15       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.